International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing

Seung Joo Kang1, Chung Hyun Tae2, Chang Seok Bang3

  • 1Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.

Clinical Endoscopy
|March 31, 2024
PubMed

Insights

Updated guidelines help manage patients on antithrombotic agents during endoscopy. These recommendations address new evidence for antiplatelet agents and anticoagulants, aiding clinical decisions.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Clinical Practice Guidelines

Background:

  • Antithrombotic agents are increasingly used in Korea due to rising cardiocerebrovascular disease and an aging population.
  • Managing patients on these agents during endoscopic procedures presents a clinical challenge.
  • Previous Korean guidelines (2020) require updating due to new evidence and international revisions.

Purpose of the Study:

  • To revise and update clinical practice guidelines for managing patients on antithrombotic agents undergoing endoscopic procedures.
  • To incorporate recent evidence on dual antiplatelet therapy and direct anticoagulant management.
  • To provide expert consensus-based recommendations for endoscopists.

Main Methods:

  • Revision of existing guidelines based on new evidence.
  • Inclusion of international expert consensus and multidisciplinary review.
  • Application of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.
  • Development of 14 specific recommendations.

Main Results:

  • The revised guidelines incorporate updated evidence on antithrombotic therapy management.
  • Recommendations address diagnostic and elective therapeutic endoscopy scenarios.
  • The guideline was developed through a consensus process involving cardiologists and international experts.

Conclusions:

  • These revised guidelines offer crucial information for endoscopists managing patients on antithrombotic agents.
  • The recommendations aim to improve patient care and safety during endoscopic interventions.
  • The guidelines will be periodically updated to reflect advancements in technology and evidence.

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
114
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
80